Patients with SCLC without neurological symptoms were similar in age, percentage female and SCLC disease extent at cancer diagnosis to those SCLC patients with neurological presentations whether they had SOX2 antibodies or not (Supplementary table 1). The gene discussed is SOX2; the disease is small cell lung carcinoma.